• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol.老年患者从医院过渡到家庭期间口服抗凝剂相关不良事件的预测因素:一项回顾性队列研究方案
BMJ Open. 2020 Sep 22;10(9):e036537. doi: 10.1136/bmjopen-2019-036537.
2
Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home.老年患者从医院过渡到家庭时发生口服抗凝剂相关不良事件的预测因子的推导和验证。
Thromb Res. 2021 Oct;206:18-28. doi: 10.1016/j.thromres.2021.07.016. Epub 2021 Aug 2.
3
Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial.出院时口服抗凝药物管理的协调(COACHeD):试点随机对照试验。
BMJ Open. 2024 May 1;14(5):e079353. doi: 10.1136/bmjopen-2023-079353.
4
Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial.出院时口服抗凝治疗协调研究(COACHeD):一项试点随机对照试验的方案
Pilot Feasibility Stud. 2022 Aug 2;8(1):166. doi: 10.1186/s40814-022-01130-z.
5
Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.在英国普通实践中使用口服抗凝剂治疗老年心房颤动患者:使用临床实践研究数据库(CPRD)数据库的队列研究方案。
BMJ Open. 2019 Dec 15;9(12):e032646. doi: 10.1136/bmjopen-2019-032646.
6
Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly.老年人中潜在可避免的抗凝剂相关出血和血栓栓塞事件的负担。
Chest. 2007 May;131(5):1508-15. doi: 10.1378/chest.06-2628. Epub 2007 Feb 22.
7
Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.西班牙巴伦西亚地区心房颤动患者口服抗凝药依从性——一项基于人群的回顾性队列研究,该研究连接了健康信息系统:研究方案
BMJ Open. 2015 Oct 19;5(10):e007613. doi: 10.1136/bmjopen-2015-007613.
8
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.抗凝治疗相关脑出血患者的抗凝逆转、血压水平和抗凝恢复。
JAMA. 2015 Feb 24;313(8):824-36. doi: 10.1001/jama.2015.0846.
9
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.急性缺血性卒中后老年房颤患者口服抗凝治疗的应用
J Am Geriatr Soc. 2017 Feb;65(2):241-248. doi: 10.1111/jgs.14688. Epub 2016 Dec 30.
10
Postsurgery paths and outcomes for hip fracture patients (POST-OP HIP PATHS): a population-based retrospective cohort study protocol.髋部骨折患者术后路径和结局(POST-OP HIP PATHS):一项基于人群的回顾性队列研究方案。
BMJ Open. 2022 Dec 29;12(12):e065599. doi: 10.1136/bmjopen-2022-065599.

引用本文的文献

1
Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study.在接受家庭姑息治疗的老年患者中使用抗凝剂和相关结局:一项回顾性队列研究。
CMAJ. 2022 Sep 12;194(35):E1198-E1208. doi: 10.1503/cmaj.220919.
2
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study.老年人出院后早期与晚期口服抗凝治疗相关的不良事件发生率:一项基于人群的回顾性队列研究。
CMAJ Open. 2021 Apr 16;9(2):E364-E375. doi: 10.9778/cmajo.20200138. Print 2021 Apr-Jun.

本文引用的文献

1
Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis.抗凝相关胃肠道出血后抗凝治疗的恢复:系统评价和荟萃分析。
Thromb Res. 2019 Mar;175:102-109. doi: 10.1016/j.thromres.2019.01.020. Epub 2019 Jan 30.
2
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.美国血液学会 2018 年静脉血栓栓塞症管理指南:抗凝治疗的最佳管理。
Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893.
3
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.美国血液学会 2018 年静脉血栓栓塞症管理指南:住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
4
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.抗栓治疗心房颤动:CHEST 指南和专家报告。
Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.
5
The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.口服抗凝药的药物-药物及药物-食物相互作用的意义
Arrhythm Electrophysiol Rev. 2018 Mar;7(1):55-61. doi: 10.15420/aer.2017.50.1.
6
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.2018 年欧洲心脏病学会关于非维生素 K 拮抗剂口服抗凝剂在心房颤动患者中应用的实用指南。
Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136.
7
Effectiveness of a financial incentive to physicians for timely follow-up after hospital discharge: a population-based time series analysis.一项针对医生出院后及时随访的经济激励措施的有效性:基于人群的时间序列分析。
CMAJ. 2017 Oct 2;189(39):E1224-E1229. doi: 10.1503/cmaj.170092.
8
Medication Without Harm: WHO's Third Global Patient Safety Challenge.无害用药:世界卫生组织的第三次全球患者安全挑战
Lancet. 2017 Apr 29;389(10080):1680-1681. doi: 10.1016/S0140-6736(17)31047-4.
9
Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure.急性心肌梗死和心力衰竭后早期医生随访与30天再入院之间的关系。
PLoS One. 2017 Jan 27;12(1):e0170061. doi: 10.1371/journal.pone.0170061. eCollection 2017.
10
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.2013 - 2014年美国急诊科门诊不良药物事件就诊情况
JAMA. 2016 Nov 22;316(20):2115-2125. doi: 10.1001/jama.2016.16201.

老年患者从医院过渡到家庭期间口服抗凝剂相关不良事件的预测因素:一项回顾性队列研究方案

Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol.

作者信息

Benipal Harsukh, Holbrook Anne, Paterson J Michael, Douketis James, Foster Gary, Thabane Lehana

机构信息

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada

出版信息

BMJ Open. 2020 Sep 22;10(9):e036537. doi: 10.1136/bmjopen-2019-036537.

DOI:10.1136/bmjopen-2019-036537
PMID:32963065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7509956/
Abstract

INTRODUCTION

Oral anticoagulants (OACs) are widely prescribed in older adults. High OAC-related adverse event rates in the early period following hospital discharge argue for an analysis to identify predictors. Our objective is to identify and validate clinical and continuity of care variables among seniors discharged from hospital on an OAC, which are independently associated with OAC-related adverse events within 30 days.

METHODS AND ANALYSIS

We propose a population-based retrospective cohort study of all adults aged 66 years or older who were discharged from hospital on an OAC from September 2010 to March 2015 in Ontario, Canada. The primary outcome is a composite of the first hospitalisation or emergency department visit for a haemorrhage or thromboembolic event or mortality within 30 days of hospital discharge. A Cox proportional hazards model will be used to determine the association between the composite outcome and a set of prespecified covariates. A split sample method will be adopted to validate the variables associated with OAC-related adverse events.

ETHICS AND DISSEMINATION

The use of data in this project was authorised under section 45 of Ontario's Personal Health Information Protection Act, which does not require review by a research ethics board. Results will be disseminated via peer-reviewed publications and presentations at conferences and will determine intervention targets to improve OAC management in upcoming randomised trials.

TRIAL REGISTRATION NUMBER

ClinicalTrials.gov Identifier: NCT02777047; Pre-results.

摘要

引言

口服抗凝剂(OACs)在老年人中广泛应用。出院后早期OAC相关不良事件发生率较高,因此有必要进行分析以确定预测因素。我们的目标是识别并验证出院时服用OAC的老年人中的临床及护理连续性变量,这些变量与30天内OAC相关不良事件独立相关。

方法与分析

我们提议对2010年9月至2015年3月在加拿大安大略省出院时服用OAC的所有66岁及以上成年人进行基于人群的回顾性队列研究。主要结局是出院后30天内因出血或血栓栓塞事件首次住院或急诊就诊或死亡的综合情况。将使用Cox比例风险模型来确定综合结局与一组预先指定的协变量之间的关联。将采用拆分样本方法来验证与OAC相关不良事件相关的变量。

伦理与传播

本项目中数据的使用已根据安大略省《个人健康信息保护法》第45条获得授权,该条不要求研究伦理委员会进行审查。结果将通过同行评审出版物以及在会议上的报告进行传播,并将确定干预目标,以在即将进行的随机试验中改善OAC管理。

试验注册号

ClinicalTrials.gov标识符:NCT02777047;预结果。